GoInVivo™ Purified Rat IgG2a, κ Isotype Ctrl 400559 from BioLegend

Product Specs
ItemGoInVivo™ Purified Rat IgG2a, κ Isotype Ctrl
CompanyBioLegend
Price $4,455.00Supplier Page View Company Product Page
Catalog Number400559
Quantity100 mg
ApplicationsFC - Quality tested, ICFC, WB, IP, ICC, IHC, FA - Reported in the literature, not verified in house
Conjugate/TagUnconjugated, Super Low Endotoxin Azide Free
Format0.2 µm filtered in phosphate-buffered solution, pH 7.2, containing no preservative
IsotypeRat IgG2a, kappa
CloneRTK2758
HostRat
ImmunogenTrinitrophenol + KLH
ClonalityMonoclonal
Antibody TypeIsotype Control
ConcentrationThe antibody is bottled at the concentration indicated on the vial, typically between 2 mg/mL and 3 mg/mL

Add to Compare List

BioLegend

8999 BioLegend Way

San Diego, California 92121

United States

Phone: 1-877-246-5343 Toll-Free, USA & Canada
1-858-768-5800 International
Fax: 1-877-455-9587

Company Profile

Website: biolegend.com

(1) Ferroptotic tumor cells reprogram tumor-associated macrophage antigen presentation to enhance the efficacy of immune checkpoint blockadeCell Rep MedMay 19, 2026Jia-Lei Sun, Yong-Chao Chu, Fu Wang, Ding-Dang Yu, Jin-Rui Liu, Ru-Chen Xu, Hua-Hua Liu, Zhuo-Ran Qi, Xuan Shi, Xiang-Nan Yu, et al.Antibody,BioLegend,Cat# 329946; RRID: AB_ 2566290 "GoInVivo™ Purified Rat IgG2a, κ Isotype Ctrl Antibody",BioLegend,Cat# 400559; RRID: AB_ 2819062 "GoInVivo™ Purified Mouse IgG1, κ Isotype Ctrl Antibody",BioLegend,Cat# 400189;

(2) Reevaluating the senolytic activity of a GLS1 inhibitor and an anti-PD-1 antibody: toward greater reproducibility and methodological rigorEMBO ReportsApril 3, 2026Shimpei Kawamoto, Haruki Horiguchi, Daisuke Torigoe, Masahiro Wakita, Koyu Ito, Sho Sugawara, Xiangyu Zhou, Takumi Mikawa, Jeong Hoon Park, Birte Kristin Jung, et al.C57BL/6 N mice were intraperitoneally injected with 250 μg of either isotype control IgG (clone RTK2758; 400563, BioLegend) or anti-mouse PD-1 antibody (clone 29F.1A12; 135234, BioLegend) every 3 days for 3 weeks.

(3) Induction of a mismatch repair deficient genotype by tailored chemical mutagenesis in experimental models of cancerCancer CellJuly 14, 2025Benoit Rousseau, Mitesh Patel, Oliver Artz, Georgios Vlachos, Shrey Patel, Omar Hayatt, Guillem Argilés, Michael B. Foote, Lingqi Luo, Rachna Shah, et al.schedule was as follows: anti PD1 antibody (Biolegend Inc., 114115) or Isotype control (Biolegend Inc.400563) 200 μg/mouse i.p. three times/week. Mice were observed daily throughout the treatment period for signs

(4) Na+/H+-exchanger 1 Enhances Antitumor Activity of Engineered NK-92 Natural Killer CellsCancer Res CommunAugust 22, 2022Yao-Yu Gong, Hongguang Shao, Yu Li, Patricia Brafford, Zachary E. Stine, Jing Sun, Dean W. Felsher, Jordan S. Orange, Steven M. Albelda, Chi V. Dangpurified anti-mouse CD279 (PD1) antibody (BioLegend, 135235) or isotype control antibody (BioLegend, 400564) via intraperitoneal injection at 8 weeks for 4 weeks and then sacrificed. Livers were weighed as surrogate

(5) Na(+)/H(+)-exchanger 1 enhances antitumor activity of engineered NK-92 natural killer cellsCancer Res CommunAugust 1, 2022Gong YY, Shao H, Li Y, Brafford P, Stine ZE, Sun J, Felsher DW, Orange JS, Albelda SM, Dang CV.purified anti-mouse CD279 (PD1) antibody (BioLegend, 135235) or isotype control antibody (BioLegend, 400564) via intraperitoneal injection at 8 weeks for 4 weeks and then sacrificed. Livers were weighed as surrogate

(6) Immunostimulatory bacterial antigen-armed oncolytic measles virotherapy significantly increases the potency of anti-PD1 checkpoint therapyThe Journal of clinical investigationJuly 1, 2021Panagioti E, Kurokawa C, Viker K, Ammayappan A, Anderson SK, Sotiriou S, Chatzopoulos K, Ayasoufi K, Johnson AJ, Iankov ID, et al.

(7) Proteome Instability Is a Therapeutic Vulnerability in Mismatch Repair-Deficient CancerCancer cellMarch 16, 2020McGrail DJ, Garnett J, Yin J, Dai H, Shih DJH, Lam TNA, Li Y, Sun C, Li Y, Schmandt R, et al.141372 GolnVivo PD1 (29F1A12),Biolegend,Cat# 135236; RRID: AB 2616837 GolnVivo Rat IgG Control,Biolegend,Cat# 400559; RRID: AB 2819062 Bacterial and Virus Strains,Bacterial and Virus Strains,Bacterial and Virus Strains DH5α,Thermo Fisher Scientific

(8) TGF-β inhibition via CRISPR promotes the long-term efficacy of CAR T cells against solid tumorsJCI insightFebruary 27, 2020Tang N, Cheng C, Zhang X, Qiao M, Li N, Mu W, Wei XF, Han W, Wang H.

(9) Prebiotic-Induced Anti-tumor Immunity Attenuates Tumor GrowthCell reportsFebruary 11, 2020Li Y, Elmén L, Segota I, Xian Y, Tinoco R, Feng Y, Fujita Y, Segura Muñoz RR, Schmaltz R, Bradley LM, et al.114112; clone RMP1–14; RRID: AB_2566090 "GoInVivo Purified Rat IgG2a, κ Isotype Ctrl",BioLegend,Cat#400560; clone RTK2758 InVivoMAb anti-mouse Thy1.2 (CD90.2),BioXCell,Cat# BE0066; clone 30H12; AB_1107682 Bacterial

(10) The lymphotoxin pathway regulates Aire-independent expression of ectopic genes and chemokines in thymic stromal cellsJournal of immunology (Baltimore, Md. : 1950)April 15, 2008Seach N, Ueno T, Fletcher AL, Lowen T, Mattesich M, Engwerda CR, Scott HS, Ware CF, Chidgey AP, Gray DH, et al.

Be the First to Write a Review!

GoInVivo™ Purified Rat IgG2a, κ Isotype Ctrl from BioLegend

Description

BioLegend

Citations (10)

Reviews

GoInVivo™ Purified Rat IgG2a, κ Isotype Ctrl from BioLegend

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map